Biologically Active Peptides
Bioactive peptide
Bioactive peptides have a protective effect against oxidative damage acting as free radical scavengers and metal ion chelators against enzymatic and non‐enzymatic peroxidation of lipids and essential fatty acids. Another field of action of bioactive peptides is related to their antimicrobial and immunomodulatory effect. In addition, the effects of numerous of these peptides have been investigated by Peptide Pharma Nova team on a variety of cancer cell lines and disease models.
Showing 829–864 of 1047 results
Nombre
Catalogue
Target
Category
Subcategory
-
Peptide name
Catalogue
PPH08-0842Target
Appetite-Boosting Peptide. The endogenous polypeptide amide Orexin B (rat, mouse) plays an important role in regulation of food intake and sleep.Category
-
Peptide name
Catalogue
PPH08-0843Target
T-cell Activating PeptideCategory
-
Peptide name
Catalogue
PPH08-0844Target
T-cell Activating Peptide, An Immune Checkpoint PeptideCategory
-
Catalogue
PPH08-0855Target
OVCA2 cooperates with apoptosis-related protein Bag-1, which indicates that OVCA2 takes part in cell proliferation. OVCA2 is thought to perform as a serine-hydrolase due to its catalytic and structural characteristics. Additionally, OVCA2 is believed to bCategory
-
Peptide name
Catalogue
PPH08-0856Target
Putative physiological regulator of gastric acid secretion, it inhibits histamine.Category
-
Peptide name
Catalogue
PPH08-0852Target
Inhibitor of gastric acid secretion and pancreatic enzyme secretion and has been shown to reduce food intake and increase energy expenditure in humans.Category
-
Peptide name
Catalogue
PPH08-0853Target
Inhibitor of gastric acid secretion and pancreatic enzyme secretion and has been shown to reduce food intake and increase energy expenditure in humans. Central injection of oxyntomodulin reduces food intake and weight gain in rodents, suggesting that oxynCategory
-
Catalogue
PPH08-0847Target
NeurohormoneCategory
-
Peptide name
Catalogue
PPH08-0904Target
p53 or TP53 is a cell cycle related transcription factor that promotes transcription of genes that induce cell cycle arrest or apoptosis in response to DNA damage or cell stresses. This tumour suppressor gene is mutated in about half of all human cancers.Category
-
Peptide name
Catalogue
PPH08-0862Target
Pituitary Adenylate Cyclase Activating Polypeptide. PACAP Selective Antagonist with high activityCategory
-
Peptide name
Catalogue
PPH08-0863Target
Pituitary Adenylate Cyclase Activating Polypeptide 27 (Human, 1-27 Amide)Category
-
Peptide name
Catalogue
PPH08-0864Target
Pituitary Adenylate Cyclase Activating Polypeptide 38 (Human)Category
-
Peptide name
Catalogue
PPH08-0922Target
High quality, quantitated heavy/light peptide calibrator for Mass Spectroscopy researchCategory
-
Peptide name
Catalogue
PPH08-0865Target
Hypotensive PeptideCategory
-
Peptide name
Catalogue
PPH08-0866Target
Hypotensive PeptideCategory
-
Peptide name
Catalogue
PPH08-0867Target
Hypotensive Peptide / Major Endogenous Form of PAMP, Potent Mas-Related G Protein-Coupled Receptor-X2 (MRGPRX2) agonist, activated by neurokinins and basic secretagogues.Category
-
Peptide name
Catalogue
PPH08-0916Target
Competitively Suppresses Glucose-Induced Insulin Response From Isolated Rat IsletsCategory
-
Catalogue
PPH08-0868Target
Adenylate Cyclase- / Bone Growth Stimulating PeptideCategory
-
Peptide name
Catalogue
PPH08-0870Target
Effective Anabolic Agent Used in the Treatment of Some Forms of OsteoporosisCategory
-
Peptide name
Catalogue
PPH08-0871Target
Effective Anabolic Agent Used in the Treatment of Some Forms of OsteoporosisCategory
-
Peptide name
Catalogue
PPH08-0899Target
PTH influences bone remodeling, which is an ongoing process in which bone tissue is alternately resorbed and rebuilt over time.Category
-
Peptide name
Catalogue
PPH08-0872Target
Osteoporosis ResearchCategory
-
Peptide name
Catalogue
PPH08-0873Target
PTH acts to increase the concentration of calcium in the blood by acting upon parathyroid hormone receptor in three parts of the body:Category
-
Peptide name
Catalogue
PPH08-0869Target
Parathyroid hormone (PTH) with hypertensive activitiesCategory
-
Peptide name
Catalogue
PPH08-0874Target
PTH regulates serum calcium levels through its effects in the kidney, intestines, and bones.Category
-
Peptide name
Catalogue
PPH08-0875Target
PTH regulates serum calcium levels through its effects in the kidney, intestines, and bones.Category
-
Peptide name
Catalogue
PPH08-0876Target
PTH regulates serum calcium levels through its effects in the kidney, intestines, and bones.Category
-
Peptide name
Catalogue
PPH08-0917Target
PARK2 is an element in a multiprotein E3 ubiquitin ligase complex which mediates the targeting of substrate proteins for proteasomal degradation. PARK2 alterations can result in Parkinson disease and autosomal recessive juvenile Parkinson disease. AlternaCategory
-
Catalogue
PPH08-0919Target
ELISA, Western blot, The PARK7 is a ubiquitously expressed protein involved in various cellular processes including spermatogenesis and fertilization, cancer, RNA-binding, androgen-receptor signaling and oxidative stress. Mutations in the PARK7 are the cCategory
-
Peptide name
Catalogue
PPH08-0910Target
The PARK7 is a ubiquitously expressed protein involved in various cellular processes including spermatogenesis and fertilization, cancer, RNA-binding, androgen-receptor signaling and oxidative stress. Mutations in the PARK7 are the cause of autosomal receCategory
-
Peptide name
Catalogue
PPH08-0918Target
The PARK7 is a ubiquitously expressed protein involved in various cellular processes including spermatogenesis and fertilization, cancer, RNA-binding, androgen-receptor signaling and oxidative stress. Mutations in the PARK7 are the cause of autosomal receCategory
-
Peptide name
Catalogue
PPH08-0905Target
The PARK7 is a ubiquitously expressed protein involved in various cellular processes including spermatogenesis and fertilization, cancer, RNA-binding, androgen-receptor signaling and oxidative stress. Mutations in the PARK7 are the cause of autosomal receCategory
-
Peptide name
Catalogue
PPH08-0921Target
Advanced Glycation End Product (AGE) / Biomarker for Glycation-Oxidative Stress (e.g. in Diabetes)Category
-
Peptide name
Catalogue
PPH08-0895Target
Microbial Product Inhibitor for Pepsin, Cathepsin D/E and Renin, Seen to inhibit Babesia parasites in vitro and in vivoCategory
-
Peptide name
Catalogue
PPH08-0877Target
Peptide T has several positive effects related to HIV disease and Neuro-AIDS.Category
-
Peptide name
Catalogue
PPH08-0878Target
Peptide T has several positive effects related to HIV disease and Neuro-AIDS.Category